ProfoundBio rakes in over $55m Series A

ProfoundBio, an oncology biotherapeutics company, has raised more than $55 million in Series A financing round.

ProfoundBio, an oncology biotherapeutics company, has raised more than $55 million in Series A financing round. The investors included Lilly Asia Venture, LYFE Capital, Sequoia Capital China and Oriza.

Source: Press Release